Skip to main content
Wendy Pang, MD, Oncology, Stanford, CA

Wendy Pang MD PhD

Hematologic Oncology


Physician

Join to View Full Profile
  • 300 Pasteur Dr# GrantStanford, CA 94305

  • Phone+1 650-723-6661

  • Fax+1 650-498-6205

Dr. Pang is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Stanford Health Care-Sponsored Stanford University
    Stanford Health Care-Sponsored Stanford UniversityFellowship, Hematology, 2014 - 2018
  • Stanford Health Care-Sponsored Stanford University
    Stanford Health Care-Sponsored Stanford UniversityResidency, Internal Medicine, 2012 - 2014
  • Stanford University School of Medicine
    Stanford University School of MedicineClass of 2010

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2013 - 2023
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Hematology
    American Board of Internal Medicine Hematology

Publications & Presentations

PubMed

Press Mentions

  • Jasper Therapeutics Initiates New Clinical Trial with National Cancer Institute to Evaluate JSP191 in GATA2-Related Myelodysplastic Syndromes
    Jasper Therapeutics Initiates New Clinical Trial with National Cancer Institute to Evaluate JSP191 in GATA2-Related Myelodysplastic SyndromesSeptember 8th, 2021
  • Jasper Therapeutics Announces Positive Data from Phase 1 Clinical Trial of JSP191 as Targeted Stem Cell Conditioning Agent in Patients with Myelodysplastic Syndromes or Acute Myeloid Leukemia Undergoing Hematopoietic Cell Transplantation
    Jasper Therapeutics Announces Positive Data from Phase 1 Clinical Trial of JSP191 as Targeted Stem Cell Conditioning Agent in Patients with Myelodysplastic Syndromes or Acute Myeloid Leukemia Undergoing Hematopoietic Cell TransplantationFebruary 8th, 2021
  • Antibody Could Increase Cure Rate for Blood, Immune Disorders
    Antibody Could Increase Cure Rate for Blood, Immune DisordersFebruary 11th, 2019

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: